期刊文献+

P16蛋白在乳腺癌中的表达及临床意义 被引量:2

THE EXPRESSION OF P16 PROTEIN IN BREAST CARCINOMA AND CLINICAL SIGNIFICANCE
暂未订购
导出
摘要 目的 :探讨P16蛋自在乳腺癌中的表达情况及其临床价值。方法 :应用SP免疫组织化学方法对 75例乳腺癌组织中CDKNI抑癌基因P16蛋白表达进行检测。结果 :P16蛋白阳性表达与淋巴结转移呈负相关 (P <0 0 5 ) ,与乳腺癌的术后生存期呈正相关 (P <0 0 5 ) ,与乳腺癌的组织学分级 ,以及肿瘤的大小无相关性。结论 :P16蛋白表达水平 ,可作为估计乳腺癌预后的重要指标。 Objective:To explore expression of P16 protein in breast carcinoma and clinical significance.Methods:The expression of P16 protein were examined by means of SP immunohistochemical technique in 75 cases of breast cancer proved by pathology.Results:The expression of P16 protein is associated with tumor genesis( P <0.05),The expression of P16 protein was in negative correlation with metastatic human breast cancer( P <0.05).The expression of P16 protein was in positive correlation with survival more than 5 years.( P<0.005).Conclusion:The levels of expression of P16 protein in breast cancer may be an important indicator of prognosis.
出处 《内蒙古医学院学报》 2002年第1期20-22,共3页 Acta Academiae Medicinae Neimongol
关键词 乳腺肿瘤 P16蛋白 免疫组化 breast neoplasms P16 protein immunohistochemistry
  • 相关文献

参考文献4

  • 1[1]Kamb, Gruis NA, Weaver- Feldhaus J, et al. A cell- cycle regulator potentially invelved in the genesis of many tumor types[J].Science, 1994; 264: 436~437
  • 2[2]Nobori T, Miura K,Wu D J,et al. Deletions of the cyclin- dependent kinase- 4 inhibitor gene in multiple human cancers[J].Nature ,1994 ;368: 753~756
  • 3[3]Reed JA, Loganzo F. Loss of expression of the P16/cyclin dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesion correlated with invasive stage of tumor progression [J].Cancer Res, 1995 ;55:27
  • 4[4]Gulley ML, Nivholls JM, Schneider BG, et al. Nasopharyngeal carcinomas frequently lack the P16/MTS1 tumor suppressor protein but consistently express the retinoblastoma gene product [J]. Am J Pathol, 1998; 152(4): 865

同被引文献12

  • 1王宏,吴金民,方勇,张行,曹厚军,周文鹏,张俊平.MMP-9与NF-кB p65在乳腺癌组织中表达的相关性及临床意义[J].实用肿瘤杂志,2005,20(6):525-528. 被引量:9
  • 2Mika A,Takenaka K,Ishikawa S[J].clin Invest,1997,100(12):2 952-2 960.
  • 3Serrano M,Hannonn GT,Beach D,et al.A new regulatory motif in cell cycle control causing[J],Nature,1993,366(16):704-707.
  • 4Mayo MW,Baldwin AS.The transcription factor-kappaB:control of oncogenesis and cancer therapy resistance[J].Biochem Biophysics Acta,2000,1470(2):M55-62.
  • 5Wang W,Abbruzzese JL,Evans DB,et al.The nuclear factor-kappaB RelA transcription factor is constitutively act human pancreatic adenocarinoma cell[J].Clin Cancer Res,1999.5(1):119-127.
  • 6Kamb A, Gruis NA, Weaver F, et al.A cell cycle regulator potentially involved in genesis of many tumor types[J].Science, 1994, 264(5 157): 436~437.
  • 7Nobori T, Miura K, Wu DJ, et al. Deletions of the cycledependent kinase-4 inhibitor gene in multiple human cancers[J]. Nature, 1994, 368 (6 483 ): 753~756.
  • 8Kamb A, Liu QY, Harshman K,et al. Rates of pl6(MTS1)mutation in primary tumors with 9p loss [J]. Science,1994,265(16):415.
  • 9Facher EA, Becich MJ,Deka A,et al. Association between human cancer and two polym orphismas occurring together in the p21WAFI/CIP1 cyclin-dependent kinase inhibitor gene[J].Cancer ,1997,79(12): 2424~2429.
  • 10Wang TC, Cardiff RD, Zukerberg L, et al. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice[J]. Nature, 1994, 23, 369(6482): 669~671.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部